GLP-1 Market
LLY $1169.60 ▼ -1.6% NVO $38.18 ▼ -0.2% PFE $27.82 ▼ -0.6% VKTX $27.73 ▼ -2.8% KLRA $10.00 ▼ -5.0% GPCR $25.67 ▼ -3.8% RHHBY $53.29 ▼ -1.4%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Diabetes Medication

Company
Leiden University Medical Center
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
5 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

5 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Oct 9, 2026

Find a Clinical Trial Near Me

See recruiting studies for Diabetes Medication and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT03937453

    A Pancreatic Cancer Screening Study in Individuals With New-Onset or Deteriorating Diabetes Mellitus

    Nuvance Health 800 participants Est. completion 2028-01-19 2 sites
    Other conditions: Pancreatic Cancer, Pancreatic Neoplasms, Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT05766735

    Treating Early Type 2 Diabetes by Reducing Postprandial Glucose Excursions: A Paradigm Shift in Lifestyle Modification

    Not yet reported Chiara Fabris, PhD 200 participants Est. completion 2027-05-31 2 sites
    Type 2 diabetes
    View official trial listing →
  • Recruiting NCT NCT06075433

    Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease According to the Complex Higher-risk Procedure

    Genoss Co., Ltd. 1000 participants Est. completion 2027-12-31 1 site
    Cardiovascular disease Other conditions: Percutaneous Coronary Intervention, Dual Antiplatelet Therapy
    View official trial listing →
  • Recruiting NCT NCT07812623

    A Twelve-Week Pilot Study Evaluating the Usability and Preliminary Effects of SugarVita 2.0 in Adults With Type 2 Diabetes

    Not yet reported Maxima Medical Center 30 participants Est. completion 2027-08-01 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT07866846

    Managing Pasireotide-associated Hyperglycaemia in Acromegaly With Ketogenic Diet

    Not yet reported Leiden University Medical Center 30 participants Est. completion 2028-04-30 1 site
    Other conditions: Acromegaly Due to Pituitary Adenoma, Hyperglycemia, Ketogenic Diet, Standard Care Control
    View official trial listing →
  • Completed NCT NCT00179374

    Improving Diabetes Outcomes With Activity, Nutrition and Medication

    Not yet reported Albert Einstein College of Medicine 556 participants Est. completion 2008-07 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00388050

    Diabetes Medication Choice

    Not yet reported Mayo Clinic 85 participants Est. completion 2008-10 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00418366

    A Study on the Effect of Kidney Disease on a Diabetes Medication (0431-008)

    Not yet reported Merck Sharp & Dohme LLC 24 participants Est. completion 2003-03
    Other conditions: Renal Insufficiency, Hemodialysis
    View official trial listing →
  • Status unknown NCT NCT00498147

    Determining Rates of Cardiovascular Complications Among Patients of a Managed Diabetes Care Program

    Group Health Centre 1213 participants Est. completion 2010-07 1 site
    Chronic kidney disease Other conditions: Disease Management, Diabetes Complications, Diabetic Vascular Complications, Diabetic Neuropathy, Diabetic Retinopathy
    View official trial listing →
  • Completed NCT NCT00518115

    Out-Patient Study in Patients With Type 2 Diabetes Mellitus Who Are Taking no Diabetes Medication or Metformin Only

    Not yet reported GlaxoSmithKline 361 participants Est. completion 2008-05 163 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00607945

    Dietary Fatty Acids As Complementary Therapy in Type 2 Diabetes Mellitus

    Not yet reported Ohio State University 48 participants Est. completion 2012-05 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01029288

    Impact of Decision Aids to Enhance Shared Decision Making for Diabetes

    Not yet reported Mayo Clinic 110 participants Est. completion 2013-01 5 sites
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01099163

    Effect of Conjugated Linoleic Acid Alone and in Conjunction With Vitamin E in Patients With Type 2 Diabetes Mellitus

    Not yet reported Shahid Beheshti University of Medical Sciences 60 participants Est. completion 2010-10 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT01204216

    Effect of Red Blood Cell Survival on a Commonly Used Diabetes Lab Test-HbA1c

    Not yet reported VA Office of Research and Development 3 participants Est. completion 2016-09-01 1 site
    Prediabetes Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01293578

    Study to Test Use of a Decision Aid in a Clinical Visit to Help Patients Choose a Diabetes Medication

    Not yet reported Mayo Clinic 550 participants Est. completion 2015-06 6 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01427660

    iDecide.Decido: Diabetes Medication Decision Support Study

    Not yet reported University of Michigan 190 participants Est. completion 2013-10 1 site Stand-alone
    Other conditions: Diabetes, Type 2
    View official trial listing →
  • Completed NCT NCT01603329

    Increasing Medication Adherence Through Physician Incentives and Messaging

    Not yet reported National Bureau of Economic Research, Inc. 734 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Medication Adherence
    View official trial listing →
  • Completed NCT NCT01620489

    Efficacy and Safety of Liraglutide Versus Placebo as add-on to Existing Diabetes Medication in Subjects With Type 2 Diabetes and Moderate Renal Impairment

    Not yet reported Novo Nordisk A/S 279 participants Est. completion 2013-08-20 97 sites
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01861756

    The Diabetes Medication Choice Cards Trial in Greece

    Not yet reported Aristotle University Of Thessaloniki 204 participants Est. completion 2014-08 8 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01937702

    A Trial Investigating the Influence of Injection Speed and Volume on the Perception of Subcutaneous Injection Pain

    Not yet reported Profil Institut für Stoffwechselforschung GmbH 80 participants Est. completion 2014-09 1 site Stand-alone
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02140645

    Ascertainment of EMR-based Clinical Covariates Among Patients Receiving Oral and Non-insulin Injected Hypoglycemic Therapy

    Boehringer Ingelheim 166613 participants Est. completion 2015-03 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02152852

    Peer Support for Achieving Independence in Diabetes

    Not yet reported Public Health - Seattle and King County 287 participants Est. completion 2016-12
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02229396

    Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo

    Not yet reported AstraZeneca 695 participants Est. completion 2017-12-28 133 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT02230488

    Intensive Case Diabetes Management (ICDM) to Prevent Readmission

    Not yet reported Washington University School of Medicine 1 participants Est. completion 2015-05 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Withdrawn NCT NCT02263677

    Evaluation of the DPP-4 Inhibitor Sitagliptin in the Treatment of Non-Alcoholic Fatty Liver Disease Using MRI

    Not yet reported University of Missouri-Columbia Est. completion 2016-01 1 site Stand-alone
    Type 2 diabetes Other conditions: Non-alcoholic Fatty Liver Disease
    View official trial listing →
  • Completed NCT NCT02269098

    The Synergy to Control Emergency Department Hyperglycemia Program for Type 2 Diabetes

    Not yet reported Medstar Health Research Institute 101 participants Est. completion 2013-12 1 site Stand-alone
    Type 2 diabetes Other conditions: Medication Adherence, HYPERGLYCEMIA
    View official trial listing →
  • Completed NCT NCT02409329

    Improving Medication Adherence Among Underserved Patients With Type 2 Diabetes

    Not yet reported Vanderbilt University Medical Center 512 participants Est. completion 2019-06-04 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02458495

    The Diabetes Medication Adherence Promotion Intervention Trial

    Not yet reported Vanderbilt University 151 participants Est. completion 2016-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02481596

    FAMS Mobile Health Intervention for Diabetes Self-care Support

    Not yet reported Vanderbilt University Medical Center 512 participants Est. completion 2018-07 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT02665689

    Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab

    Not yet reported Prof. Dr. Antonia M. Joussen 4 participants Est. completion 2018-09-07 1 site
    Other conditions: Visual Acuity Reduced Transiently, Macular Edema, Cystoid
    View official trial listing →
  • Completed NCT NCT02749032

    Feed-Back Suppression of Meal-Induced Glucagon-like Peptide 1 (GLP-1) Secretion

    Not yet reported Michael A. Nauck 24 participants 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02828995

    Evaluating the Influence of Diabetes Stigma on Medication Adherence

    Vanderbilt University Medical Center 508 participants Est. completion 2017-12 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT02998970

    Effects of Empagliflozin on Cardiac Structure in Patients With Type 2 Diabetes

    Not yet reported Unity Health Toronto 97 participants Est. completion 2018-09 1 site
    Cardiovascular disease Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT03109951

    Abnormal Blood Sugar Tests in Diabetic Patients During Colonoscopy Preparation

    Not yet reported Catholic Kwandong University 187 participants Est. completion 2019-12-31 1 site
    Type 2 diabetes Other conditions: Colonoscopy
    View official trial listing →
  • Completed NCT NCT03202563

    Trial to Evaluate the Efficacy on Glycemic Variability and Safety of Gemigliptin Compared With Dapagliflozin Added on Metformin Alone or Diabetes Medication Naïve Patient in Type 2 Diabetes Mellitus (Stable II Study)

    Not yet reported LG Chem 71 participants Est. completion 2018-12-07 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT03374098

    Pilot of Home Visitation Services for Patients With a Diabetes Diagnosis

    Not yet reported Delta Health Alliance 150 participants Est. completion 2022-12-31 1 site Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT03438162

    Impact of Pharmacotherapeutic Education on Medication Adherence and Adverse Outcomes in Type 2 Diabetes

    Not yet reported University Hospital Dubrava 130 participants Est. completion 2018-07-01 1 site Stand-alone
    Type 2 diabetes Other conditions: Education, Drug-Related Side Effects and Adverse Reactions
    View official trial listing →
  • Status unknown NCT NCT03753568

    Effect of an Electronic Reminder System on Direct Oral Anticoagulant and Oral Diabetes Medication Adherence

    Not yet reported Helsinki University Central Hospital 100 participants Est. completion 2019-09-01 1 site
    Type 2 diabetes Other conditions: Anticoagulant Drugs
    View official trial listing →
  • Completed NCT NCT04028076

    Improving Diabetes Medication Adherence for African Americans in Madison and Milwaukee Through Peer Support

    Not yet reported University of Wisconsin, Madison 20 participants Est. completion 2020-10-05 1 site
    Type 2 diabetes Other conditions: Medication Adherence, Medication Nonadherence, Peer Support
    View official trial listing →
  • Completed NCT NCT04315688

    A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in Russia

    Novo Nordisk A/S 494 participants Est. completion 2021-08-02 40 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04497792

    Safety and Efficacy of Empagliflozin for Patients With Diabetes Mellitus and Planned Percutaneous Coronary Interventions

    Not yet reported Research Institute for Complex Problems of Cardiovascular Diseases, Russia 40 participants Est. completion 2019-11 Stand-alone
    Cardiovascular disease Other conditions: Diabetes Mellitus, Percutaneous Coronary Intervention
    View official trial listing →
  • Completed NCT NCT04738591

    mHealth Intervention to Support Diabetes Medication Adherence (Pilot Study)

    Not yet reported Fundació d'investigació Sanitària de les Illes Balears 207 participants Est. completion 2021-06-28 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT04964388

    Effect of GLP-1 Receptor Agonists on Trabecular Bone Score

    Not yet reported University of Mississippi Medical Center 5 participants Est. completion 2023-07-01 1 site Stand-alone
    Type 2 diabetes Other conditions: Osteoporosis, Postmenopausal
    View official trial listing →
  • Status unknown NCT NCT04976283

    Effect of Oral Anti-diabetic Medication on Liver Fat in Subjects With Type II Diabetes and Non-alcoholic Fatty Liver

    Not yet reported Getz Pharma 123 participants Est. completion 2023-11-15 1 site
    Type 2 diabetesMASHMASLD
    View official trial listing →
  • Status unknown NCT NCT04997512

    Freestyle Libre and Hospital Admissions in Type 2 Diabetes

    Not yet reported University of Leeds 300 participants Est. completion 2025-08-01 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05006872

    mHealth Intervention to Support Diabetes Medication Adherence

    Not yet reported Fundació d'investigació Sanitària de les Illes Balears 742 participants Est. completion 2023-04-30 1 site
    Type 2 diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT05040087

    Changing the Natural History of Type 2 Diabetes ("CHANGE" Study)

    Not yet reported Foundation for Atlanta Veterans Education and Research, Inc. 127 participants Est. completion 2028-06-30 1 site Added to GLP-1
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05463705

    Addressing Diffusion of Responsibility and Prescribing Burden to Improve Use of Diabetes Medications

    Not yet reported Brigham and Women's Hospital 1580 participants Est. completion 2024-08-22 1 site Stand-alone
    Other conditions: Diabetes, SGLT-2i and GLP-1RA Therapies, Diffusion of Responsibility, Prescribing Burden
    View official trial listing →
  • Completed NCT NCT06000813

    REACH-Es: Adapting a Digital Health Tool to Improve Diabetes Medication Adherence Among Latino Adults

    Not yet reported Massachusetts General Hospital 70 participants Est. completion 2026-05-27 1 site Stand-alone
    Type 2 diabetes Other conditions: Medication Adherence
    View official trial listing →
  • Completed NCT NCT07298837

    Turtle Therapy on HbA1c and Self-Efficacy Levels With Type 2 Diabetes

    Not yet reported Karadeniz Technical University 51 participants Est. completion 2024-11-01 1 site Stand-alone
    Type 2 diabetes Other conditions: Pet-Human Bonding
    View official trial listing →
  • Not yet recruiting NCT NCT07599852

    MEDBRIDGE-Guided NCM/CHW Post-Discharge Support for High-Risk T2D Patients

    Not yet reported University of Alabama at Birmingham 45 participants Est. completion 2031-04-30 2 sites
    Type 2 diabetes Other conditions: Medication Adherence, Care Transition, Medication Discrepancy
    View official trial listing →
  • Active, not recruiting NCT NCT07757464

    Pre-emptive Insulin to Prevent High Glucose After a Knee Steroid Injection in Adults With Type 2 Diabetes

    Not yet reported, Not yet reported Shifa International Hospital 125 participants Est. completion 2027-01-30 1 site Stand-alone
    Type 2 diabetesOsteoarthritis
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.